Filtered By:
Cancer: Leukemia

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 266 results found since Jan 2013.

Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system
CONCLUSIONS: The current CML treatment target is a cure that leads to normal age and gender-adjusted survival with a "normal" quality of life. Cardiovascular disorders are one of the major obstacles to reaching this target in CML patients. The treatment choices for CML patients must include a cardiovascular perspective.PMID:37401285 | DOI:10.26355/eurrev_202306_32786
Source: European Review for Medical and Pharmacological Sciences - July 4, 2023 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research

AHA News: Young Girl Who Endured Heart Defect and Stroke Is Now a Healthy Adult
THURSDAY, June 22, 2023 (American Heart Association News) -- Seeing Shelby Lombardo ' s white blood cell counts periodically spike, her pediatrician thought the then-4-year-old had leukemia. But a test for the disease came back negative. Other doctors...
Source: Drugs.com - Daily MedNews - June 22, 2023 Category: General Medicine Source Type: news

Cancers, Vol. 15, Pages 3060: Arterial Thrombosis in Patients with Acute Myeloid Leukemia: Incidence and Risk Factors
Conclusions: Our study showed that patients with AML are at increased risk of ATE. The risk was increased in patients with cardiovascular comorbidities, previous thrombosis, adverse cytogenetic risk as well as BMI > 30.
Source: Cancers - June 5, 2023 Category: Cancer & Oncology Authors: Mirjana Mitrovic Nikola Pantic Nikica Sabljic Zoran Bukumiric Marijana Virijevic Zlatko Pravdic Mirjana Cvetkovic Jovan Rajic Jelena Bodrozic Violeta Milosevic Milena Todorovic-Balint Ana Vidovic Nada Suvajdzic-Vukovic Darko Antic Tags: Article Source Type: research

Viruses, Vol. 15, Pages 1235: Ischaemic Stroke Occurring in a Patient Treated with Monoclonal Antibodies for COVID-19
In conclusion, among several side effects that have been described during the treatment of COVID-19 with sotrovimab, ischaemic stroke was not reported. Therefore, we here report a rare case of ischaemic stroke with early clinical manifestation after the administration of sotrovimab for the treatment of moderate COVID-19 in an immunocompromised patient for the first time.
Source: Viruses - May 25, 2023 Category: Virology Authors: Antonio Lobasso Ciro di Gennaro Maria Rita Poggiano Antonio Vasta Raffaele Angelo Nicola Ranucci Roberto Lobianco Anna Giacoma Tucci Enrico Cavagli à Pierpaolo Di Micco Tags: Case Report Source Type: research

Judges meeting children: 'Being heard
Thirty years ago, 15-year-old ‘A’ was admitted to hospital with pallor and bruising, having been taken ill on a Saturday afternoon on the football terraces, thereafter diagnosed with leukaemia. Treatment was started, but the child and his family were devout Jehovah’s Witnesses and refused to consent to a transfusion of blood products. The hospital authority sought the permission of the court1 to transfuse the boy. Blood and platelets were becoming urgently needed: his haemoglobin 4.6 g/dL, white cells 1.5, platelets 37. Evidence was adduced that with a further fall in haemoglobin, the risk to A’s li...
Source: Archives of Disease in Childhood - April 19, 2023 Category: Pediatrics Authors: Wheeler, R. Tags: Clinical law for clinical practice Source Type: research

Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease
CONCLUSIONS: Use of a common metric to quantify the magnitude and type of neurocognitive dysfunction across at-risk groups of participants by disease shows that participants perform below age-expected norms in multiple domains and experience dysfunction differently than one another. This approach highlights patterns of dysfunction that can inform disease- and domain-specific interventions.PMID:37036272 | DOI:10.1002/pbc.30299
Source: Cancer Control - April 10, 2023 Category: Cancer & Oncology Authors: Claire E Fraley Jamie S Neiman Charlotte R Feddersen Claire James Taylor G Jones Margit Mikkelsen Rachelle Nuss Alyssa M Schlenz Amanda C Winters Adam L Green Bruce E Compas Source Type: research

Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease
CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.PMID:36951061 | DOI:10.1161/ATVBAHA.122.318928
Source: Arteriosclerosis, Thrombosis and Vascular Biology - March 23, 2023 Category: Cardiology Authors: Nadia Akhiyat Terra L Lasho Morsaleh Ganji Takumi Toya Chang-Xin Shi Xianfeng Chen Esteban Braggio Ali Ahmad Michel T Corban Keith Stewart Jenna Fernandez Zhuoer Xie Christy Finke Lilach O Lerman Mrinal M Patnaik Amir Lerman Source Type: research